HS-10384

· Hansoh BioMedical R&D Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HS-10384, covering 2024-05-01 to 2024-05-01. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Find the Best Dose of HS-10384 to Treat Vasomotor Symptoms in Postmenopausal Women [Phase 2]